NeoVentures Biotechnology Inc.
NeoVentures Biotechnology Inc. is a leading independent Canadian company actively engaged in research, development and commercialization of agricultural biotechnology. The company has established global leadership in two areas; the development of aptamer diagnostic applications and the application of high throughput proteomics as a crop genetics discovery tool. NeoVentures was the first company globally to market an aptamer based diagnostic with their OTA-Sense technology for the detection of ochratoxin A in wine, beer and grain. They are following this success with ongoing product development for other commercially relevant targets including rapid varietal identification. NeoVentures has developed proprietary software and databases for the use of proteomics as a means of discovering novel protein sequences in wheat, and for the characterization of post-translational modifications of target proteins. The company’s business model is simple. We will be global leaders in regard to expertise and intellectual property over the next generation of tools for the analysis of grain and the improvement of crops. We will use this global leadership to create and sell products of commercial value. At NeoVentures we are committed to doing nothing less than creating the future of agriculture.
contact: Greg Penner or Ximena Vedoya 519.858.5052
website: www.neoventures.ca